Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
10 | 4 | IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY | 1369268 |
144 | 3 | HEPATITIS C VIRUS//HEPATITIS C//HEPATITIS B VIRUS | 65438 |
45 | 2 | HEPATITIS C VIRUS//HEPATITIS C//HCV | 31075 |
4926 | 1 | NS5B POLYMERASE//NS5B//NS3 PROTEASE | 1729 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | NS5B POLYMERASE | authKW | 1165031 | 4% | 85% | 75 |
2 | NS5B | authKW | 683881 | 4% | 49% | 77 |
3 | NS3 PROTEASE | authKW | 607776 | 3% | 68% | 49 |
4 | HCV NS5B POLYMERASE | authKW | 603445 | 2% | 95% | 35 |
5 | HCV | authKW | 271728 | 15% | 6% | 253 |
6 | NS3 HELICASE | authKW | 262444 | 1% | 60% | 24 |
7 | NS3 | authKW | 261979 | 3% | 29% | 49 |
8 | NS3 4A PROTEASE | authKW | 236207 | 1% | 72% | 18 |
9 | HCV NS5B POLYMERASE INHIBITORS | authKW | 174971 | 1% | 80% | 12 |
10 | NON NUCLEOSIDE NS5B INHIBITOR | authKW | 164040 | 1% | 100% | 9 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Chemistry, Medicinal | 20866 | 33% | 0% | 564 |
2 | Virology | 10478 | 19% | 0% | 327 |
3 | Chemistry, Organic | 3610 | 22% | 0% | 372 |
4 | Biochemistry & Molecular Biology | 1491 | 27% | 0% | 470 |
5 | Pharmacology & Pharmacy | 1091 | 17% | 0% | 289 |
6 | Gastroenterology & Hepatology | 277 | 5% | 0% | 78 |
7 | Biochemical Research Methods | 192 | 4% | 0% | 77 |
8 | Microbiology | 191 | 6% | 0% | 101 |
9 | Biophysics | 166 | 5% | 0% | 80 |
10 | Biotechnology & Applied Microbiology | 68 | 4% | 0% | 73 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | ANTIVIRAL THER Y | 146301 | 1% | 47% | 17 |
2 | METAB VIRAL DIS EXCELLENCE DRUG DISCOVERY | 93723 | 1% | 43% | 12 |
3 | MRL ROME | 81186 | 0% | 64% | 7 |
4 | IST RIC BIOL MOL P ANGELETTI SPA | 72906 | 0% | 100% | 4 |
5 | IRBM | 69988 | 1% | 30% | 13 |
6 | MED CHEM ORGAN PHARMACEUT CHEM | 59645 | 0% | 55% | 6 |
7 | METAB ANTIVIRAL DIS EXCELLENCE DRUG DISCOVE | 54680 | 0% | 100% | 3 |
8 | R4CQ | 54680 | 0% | 100% | 3 |
9 | ANTIVIRAL THER EUT | 36453 | 0% | 100% | 2 |
10 | HCV BIOL | 36453 | 0% | 100% | 2 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 41723 | 14% | 1% | 243 |
2 | JOURNAL OF MEDICINAL CHEMISTRY | 9630 | 6% | 1% | 108 |
3 | ANTIVIRAL RESEARCH | 8033 | 2% | 1% | 40 |
4 | JOURNAL OF VIROLOGY | 5263 | 6% | 0% | 109 |
5 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 3677 | 4% | 0% | 71 |
6 | BIOORGANIC & MEDICINAL CHEMISTRY | 3456 | 3% | 0% | 51 |
7 | ACS MEDICINAL CHEMISTRY LETTERS | 3128 | 1% | 1% | 16 |
8 | ANTIVIRAL THERAPY | 1825 | 1% | 1% | 14 |
9 | JOURNAL OF VIRAL HEPATITIS | 1773 | 1% | 1% | 15 |
10 | LETTERS IN DRUG DESIGN & DISCOVERY | 1772 | 1% | 1% | 12 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NS5B POLYMERASE | 1165031 | 4% | 85% | 75 | Search NS5B+POLYMERASE | Search NS5B+POLYMERASE |
2 | NS5B | 683881 | 4% | 49% | 77 | Search NS5B | Search NS5B |
3 | NS3 PROTEASE | 607776 | 3% | 68% | 49 | Search NS3+PROTEASE | Search NS3+PROTEASE |
4 | HCV NS5B POLYMERASE | 603445 | 2% | 95% | 35 | Search HCV+NS5B+POLYMERASE | Search HCV+NS5B+POLYMERASE |
5 | HCV | 271728 | 15% | 6% | 253 | Search HCV | Search HCV |
6 | NS3 HELICASE | 262444 | 1% | 60% | 24 | Search NS3+HELICASE | Search NS3+HELICASE |
7 | NS3 | 261979 | 3% | 29% | 49 | Search NS3 | Search NS3 |
8 | NS3 4A PROTEASE | 236207 | 1% | 72% | 18 | Search NS3+4A+PROTEASE | Search NS3+4A+PROTEASE |
9 | HCV NS5B POLYMERASE INHIBITORS | 174971 | 1% | 80% | 12 | Search HCV+NS5B+POLYMERASE+INHIBITORS | Search HCV+NS5B+POLYMERASE+INHIBITORS |
10 | NON NUCLEOSIDE NS5B INHIBITOR | 164040 | 1% | 100% | 9 | Search NON+NUCLEOSIDE+NS5B+INHIBITOR | Search NON+NUCLEOSIDE+NS5B+INHIBITOR |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |